Carillon Tower Advisers
MYOK

Carillon Tower Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Carillon Tower Advisers’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-201,017
Closed -$27.4M – 500
2020
Q3 		$27.4M Buy
201,017
+90,679
+82% +$9.64M 0.37% 88
2020
Q2 		$10.7M Buy
+110,338
New +$9.2M 0.08% 289

Carillon Tower Advisers's MYOK Position: Q4 2020 in Review

Carillon Tower Advisers sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 201,017 shares — an estimated $27.4M sold.

Carillon Tower Advisers first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $27.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Carillon Tower Advisers reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 201,017 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $27.4M.
  • Carillon Tower Advisers first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Carillon Tower Advisers's MyoKardia, Inc. Common Stock position peaked at $27.4M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.